Melacine melanoma vaccine: Will begin this year a Phase III trial in 300 patients, comparing the agent given with interferon alfa-2b to interferon alone. End po

Ribi ImmunoChem Research Inc. (RIBI), Hamilton, Mont.

Read the full 83 word article

How to gain access

Continue reading with a
two-week free trial.